WEBINAR: Utilizing Available Biomarkers to Tailor and Individualize Therapy in Diabetes

SPONSORED BY: DiaSorin
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Assistant Professor of Medicine, Section of Endocrinology, Diabetes, and Metabolism, Center for Metabolic Disease and Research, Lewis Katz School of Medicine at Temple University
    Biography
      Dr. Ajay Rao is a board-certified endocrinologist specializing in diabetes and cardiovascular disease and the Lewis Katz School of Medicine at Temple University in Philadelphia, PA. Dr. Rao completed his Internal Medicine residency training at the Lahey Clinical Medical Center in Burlington, MA and followed this with a 2-year clinical endocrinology fellowship at the Tulane University Health Sciences Center in New Orleans, LA where he was involved in landmark clinical trials in diabetes such as ACCORD and TINSAL-T2D. He also went through a critical care fellowship at the University of Pittsburgh Medical Center in Pittsburgh, PA before finishing a 3-year research fellowship at the Brigham and Women's Hospital/Harvard Medical School in Boston, MA. Dr. Rao also received a Masters in Medical Sciences from the Harvard Medical School. His clinical expertise is in diabetes and cardiovascular disease and has research interests in diabetes and residual cardiovascular risk.

    Abstract:

    Almost 1.5 million Americans are diagnosed with diabetes every year.  In 2012 alone, close to 10% of the population has diabetes and about a third of these individuals do not even know they have diabetes.

    More importantly, diabetes remains the 7th leading cause of death in the United States.  In the US, close to $245 billion is spent on individuals with diabetes.  Rendering patients under good glucose control remains the cornerstone of diabetes management.  However, tailoring treatment to the individual is crucial in achieving these goals.  In this talk, Dr. Ajay Rao will go over the laboratory tools available to clinicians to guide their choice of therapeutics for patients with diabetes.

    Learning Objectives:

    • Understand the epidemiology of Type 1 and Type 2 Diabetes
    • Understand the complexities in distinguishing Type 1 from Type 2 Diabetes in the modern-day clinical setting
    • Understand the role of utilizing available biomarkers in order to tailor therapy in diabetes 

    Show Resources
    You May Also Like
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    Loading Comments...